COMPANY CHRONOLOGY
MECHNIKOV Institute is a
Project for the transfer of influenza vaccine technology, construction and equipment of the biotechnological products production plant in Managua, Republic of Nicaragua.

Our production capacity: up to 30 million doses of influenza vaccine per season. We are the only biotech plant in Central America, built in accordance with WHO requirements and GMP standards.
April 27, 2014
Signature of the Memorandum between IICVSSP of Russia and INSS of Nicaragua.

July 12, 2014
Meeting of the Presidents of Russia and Nicaragua.
February 2015
Our company works according to the principle of individual approach to every client. This method allows us to achieve success in problems of all levels.
March 23-26, 2015
Holding of the First Session of the PAHO Technical Committee on influenza vaccine technology transfer to Nicaragua (CECMED, Cuba).
May-June 2015
Inspection of the IICVSSP influenza vaccine production plant by CECMED, Cuba.
December 2015
Start of construction of the MECHNIKOV Institute Plant.
February 2016
Obtaining GMP Certificate and Sanitary Registry in the name of IICVSSP issued by CECMED, Cuba (ARN of regional reference according to PAHO).

April 2016
Registration of the IICVSSP in the PAHO Revolving Fund as a provider of influenza vaccine.


October 22, 2016
Completion of construction of the MECHNIKOV Institute Plant.


December 2016

Start of commissioning and adjustment, validation and certification works of the MECHNIKOV Institute Plant.


January 2019
Comprehensive GMP certification inspection of the MECHNIKOV Institute Plant by CECMED, Cuba and Pharmacy Directorate, Nicaragua.



March 2019
Obtaining the GMP Certificate issued by CECMED, Cuba in favor of the MECHNIKOV Institute Plant.
April 2019
Start of production, filling of the first commercial batches of the influenza vaccine.

The MECHNIKOV Institut is preparing to become a covid control center in Central America with the production of the COVIVAC vaccine.
To date, the MECHNIKOV Institute is bottling two vaccines, Flu-m and Vaif, protecting the populations of Central America and the Caribbean from influenza outbreaks.